Management of Intracoronary Thrombus in ST-Segment Elevation Myocardial Infarction: A 2025 Appraisal
Journal of Cardiovascular Intervention · 2026 · 5 (2) · 79
DOI: 10.54912/jci.2025.0024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Intervention, 2026. Verfasst von Debabrata Dash und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Large thrombus burden (LTB) has been reported in a significant number of patients admitted with ST-segment elevation myocardial infarction (STEMI) in contemporary practice.The optimal invasive management of intracoronary thrombus during primary percutaneous coronary intervention remains a major challenge for interventionists.LTB may lead to distal embolization, no or slow reflow, or embolization into a non-culprit vessel and is associated with adverse cardiovascular outcomes.Currently, no ideal management strategy is available.In this manuscript, the authors discuss the currently available strategies for managing LTB in patients presenting with STEMI.
Zitieren
APA
Dash, D., Ahmed, N., Mody, R., Dash, U., & Malan, S. R. (2026). Management of Intracoronary Thrombus in ST-Segment Elevation Myocardial Infarction: A 2025 Appraisal. Journal of Cardiovascular Intervention, 5(2), 79. https://doi.org/10.54912/jci.2025.0024
Vancouver
Dash D, Ahmed N, Mody R, Dash U, Malan SR. Management of Intracoronary Thrombus in ST-Segment Elevation Myocardial Infarction: A 2025 Appraisal. Journal of Cardiovascular Intervention. 2026;5(2):79. doi:10.54912/jci.2025.0024
BibTeX
@article{Dash2026,
author = {Dash, Debabrata and Ahmed, Naveed and Mody, Rohit and Dash, Umanshi and Malan, Sugandhna Reno},
title = {Management of Intracoronary Thrombus in ST-Segment Elevation Myocardial Infarction: A 2025 Appraisal},
journal = {Journal of Cardiovascular Intervention},
year = {2026},
volume = {5},
number = {2},
pages = {79},
doi = {10.54912/jci.2025.0024}
}
EUVIMED